Meet With... Frazier Healthcare Partners

Add this event to your calendar:
29/03/2018 12:30 29/03/2018 15:00 America/Los_Angeles Meet With... Frazier Healthcare Partners Johnson & Johnson Innovation, JLABS , 329 Oyster Point Blvd , South San Francisco , CA JLABS Bay Area false DD/MM/YYYY
March
29
Event

Meet With... Frazier Healthcare Partners

Johnson & Johnson Innovation, JLABS , 329 Oyster Point Blvd , South San Francisco , CA

March 29, 2018 from 12:30 PM to 15:00 PM (PST)

$10 - $35


With over 26 years of exclusively investing in over 170 healthcare companies, Frazier Healthcare Partners has a great deal of experience building successful life science businesses. On March 29, 2018, Jamie Brush MD, and Patrick Heron, MBA will be visiting JLABS @ SSF to provide an overview of Frazier Healthcare Partners' unique investment strategies and meet 1-on-1 with pre-selected companies.

*The one-on-one application process is separate from the event registration process. Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due by February 22nd. Apply Here.

Program Overview:
Frazier Healthcare Partners is committed to helping great healthcare companies who are working hard to make a difference in the future of life sciences. The firm has partnered with exceptional entrepreneurs at all stages and focuses on therapeutic development. With $3 billion under management, investments in over 170 companies and 35 IPOs, Frazier Healthcare Partners has built a team with deep knowledge and scientific expertise that enables company building.

Jamie Brush, MD and Patrick Heron, MBA will be in attendance to provide an overview presentation of the firm's areas of interest. They will be on hand to meet with a handful of applicants 1-on-1 after the presentation. To be considered for a 1-on-1 meeting, please complete the information required here. Applications due by Feb 22, 2018.


Speaker:
James W. Brush, M.D. | Senior Associate, Frazier Healthcare Partners read bio»
Patrick Heron, MBA | Managing General Partner, Frazier Healthcare Partners read bio»


Agenda:
10:30AM | Registration and Networking
11:00 AM | Presentation and Q&A
12:00 PM | Networking Lunch
1:00-5:15 PM | One-on-One Meeting* (30 - minute meetings)

*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due February 22,, 2018. Apply Here.


Fees:

Presentation
$25 | General Public
$35 | Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on March 27th (or sold out).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Apply to meet one-on-one with Jamie Brush of Frazier Healthcare Partners. Your application will be reviewed and you will be notified of acceptance on March 13th. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved. Applications are due February 22nd.


Speakers' Biographies:

James W. Brush, M.D. | Senior Associate, Frazier Healthcare Partners
Jamie joined Frazier Healthcare Partners in 2016 and focuses on investment identification, due diligence, and deal closing.

Before joining Frazier, Jamie was a management consultant with the Boston Consulting Group, where he was a core member of the Healthcare Practice. In this capacity, he led projects involving Biotechnology mergers and acquisitions, R&D, manufacturing and business development strategy.

Jamie received his M.D. from the University of Southern California, where he was inducted into Alpha Omega Alpha honors society, and his B.A. from Middlebury College. He completed his postgraduate training in Internal Medicine at Beth Israel Deaconess Medical Center in Boston. He has co-authored several papers in top-tier journals on genomic instability and its role in cancer, and is a member of the board of directors of Longwood Symphony Orchestra.


Patrick Heron, MBA| Managing General Partner, Frazier Healthcare Partners

Patrick is a Managing General Partner of Frazier's Life Sciences team. He joined the firm in 1999 and opened Frazier's Menlo Park office in 2003. Throughout his 12 years as General Partner, Patrick has led or co-led investments across nearly 20 companies.

Patrick has successfully partnered with entrepreneurs across a range of company types and stages, from early – stage anti-infectives companies to >$100M commercial-stage dermatology companies. Patrick has also been active in company formation around both early – and later – stage assets. He has led and served as director for many successful Frazier Life Sciences investments, including Tobira Therapeutics (acquired by Valeant), MedPointe (acquired by Meda), and Collegium (NASDAQ: COLL). He currently serves on the boards of Imago BioSciences, Iterum Therapeutics, Silvergate Pharmaceuticals, SutroVax and Zavante Therapeutics.

Prior to joining Frazier, Patrick helped develop McKinsey & Company's West Coast biotechnology consulting practices, where he led projects involving mergers and acquisitions, product launches, sales force optimization, corporate partnering, and research prioritization.

Patrick received his M.B.A. from Harvard Business School. He also holds a B.A. from the University of North Carolina at Chapel Hill, where he is a Phi Betta Kappa graduate and Morehead Scholar.


About the Meet With... Series:

The purpose of the Meet with series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCI, NCATS, NINDS, Allegory Venture Partners, Clarus Ventures, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, OrbiMed, Osage University Partners, Spectrum 28, Quark Venture, and AbbVie Ventures.

Venue:
JLABS @ SSF
329 Oyster Point Blvd - 3rd Floor
South San Francisco, California
Map It


JLABS Bay Area

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS. About Johnson & Johnson Innovation Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com or follow @JNJInnovation.

Event contact


Related content